We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD)
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …

We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …

Major depression is a highly prevalent severe mood disorder that is treated with antidepressants.
The molecular targets of antidepressants require definition. We investigated the role of …

Alzheimer's disease is an age-related progressive neurodegenerative disorder with an
enormous unmet medical need. It is the most common form of dementia affecting ∼5% of adults …

Neurochemical dementia diagnostics (NDD) can significantly improve the clinically based
categorization of patients with early dementia disorders, and the cerebrospinal fluid (CSF) …

Background Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia.
Recent large genome-wide association studies (GWAS) identified the first strongly supported …

Creutzfeldt–Jakob disease (CJD) is a rare, fatal, neurodegenerative disease caused by a
transmissible agent designated as proteinaceous infectious agent (prion). Searching for …